(Q35770929)

10 August 2017

Influences of allergic rhinitis on sleep (English)

1 reference

10 August 2017

1 reference

Berrylin J Ferguson

1

1 reference

10 August 2017

1 May 2004

1 reference

Otolaryngology—Head and Neck Surgery

10 August 2017

1 reference

10 August 2017

130

1 reference

10 August 2017

5

1 reference

10 August 2017

617-629

1 reference

Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids

10 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Immune mediators in allergic rhinitis and sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Quality of life consequences of sleep-disordered breathing

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Pollen and mold exposure impairs the work performance of employees with allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Acoustic rhinometry findings in patients with mild sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Circadian and circannual rhythms of allergic rhinitis: an epidemiologic study involving chronobiologic methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Twenty-four hour pattern in symptom intensity of viral and allergic rhinitis: treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Brain-immune interactions in sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

An interpretation method for objective assessment of nasal congestion with acoustic rhinometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Mediators of inflammation and the inflammatory process

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Clinical manifestations of the release of histamine and other inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Biological effects of histamine: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Histamine H2 receptor-mediated airway goblet cell secretion and its modulation by histamine-degrading enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Comparative nasal effects of bradykinin and histamine: influence on nasal airways resistance and plasma protein exudation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of "one linked airway disease".

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Effects of prostaglandin D2, lipoxins and leukotrienes on sleep and brain temperature of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Biochemical regulation of non-rapid-eye-movement sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Nasal inflammation in patients with obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Mediators of nasal blockage in allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

A randomized, placebo-controlled trial of the effect of antihistamine or corticosteroid treatment in acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Effects of intranasal azelastine on the response to nasal allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Reduced Allergen-Induced Nasal Congestion and Leukotriene Synthesis with an Orally Active 5-Lipoxygenase Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Comparative role of peptide leukotrienes and histamine in the development of nasal mucosal swelling in nasal allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

Urinary leukotriene E4 in the assessment of nocturnal asthma†

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2004.02.001

10.1016/J.OTOHNS.2004.02.001

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15138430